-
The US Food and Drug Administration has granted “fast track” status to Novavax’s experimental coronavirus vaccine, the company announced Monday.
The designation will allow the
-
The Trump administration is weighing a fast-tracked process that would allow AstraZeneca’s coronavirus vaccine to be used in the US before November’s presidential election, a new report says. One plan under consideration would see the Food and Drug Administration issue an “emergency use authorization” for the British drugmaker’s vaccine candidate in October, the Financial Times …
-
Tom Ford is being slammed by fashion insiders and fans alike after ruffling fashionable feathers yet again as the chairman of the Council of Fashion Designers of America. This year’s CFDA Awards — considered the fashion world’s Oscars — was postponed, but the nominations came out this week to a flurry of criticism, including allegations …
-
Shares of Pfizer fell nearly 7 percent on Monday after an independent data monitoring committee determined the drugmaker’s breast cancer treatment was unlikely to meet the main goal of a late-stage study. The treatment, Ibrance, was being tested along with the standard of care for early breast cancer in men and women, against standard of …
-
US health regulators are telling five drugmakers to recall their versions of a widely used diabetes medication after laboratory tests found elevated levels of a contaminant linked to cancer. The Food and Drug Administration said late Thursday that several batches of the drug metformin tested positive for unsafe levels of N-Nitrosodimethylamine, a possible cancer-causing chemical …
-
The Food and Drug Administration on Friday warned against unsupervised use of the malaria drug chloroquine and its derivative hydroxychloroquine to treat coronavirus after reports of “serious” poisoning and deaths. The agency issued a drug safety warning, saying it is aware of reports of “serious heart rhythm problems” in coronavirus patients who took the drugs. “Hydroxychloroquine and chloroquine …
-
US health regulators are telling drugmakers to immediately pull their popular heartburn drugs off the market after determining that a contamination issue with the medications poses a greater risk than previously thought. The move from the Food and Drug Administration Wednesday applies to all prescription and over-the-counter versions of ranitidine, best known by the brand …
-
The Met Gala isn’t the only glitzy red carpet being postponed in the face of the coronavirus pandemic.